The analysis demonstrated increased levels of cells double positive for CD4/GL13 and CD8/GL13 in the pancreatic cancer microenvironment that reached a statistical significance in the TC versus NAT (Figure 4A,B, p-value < 0.05). This evidence concerns the gene CD8A and familial pancreatic carcinoma.